Follow the 이지바이오 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Food & Beverage sector, 이지바이오 has logged 36 insider filings. The latest transaction was disclosed on 8 June 2026 (Other). Among the most active insiders: 이지홀딩스. Every trade is accessible without an account.
36
Insider Decl.
0
Thresholds
·
14 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.